HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

213Bi-cDTPA-9.2.27 monoclonal antibody

in Phase 1 dose escalation trials for treating metastatic melanoma
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results